Gilead's New Cancer Gene Therapy Has Been Approved by the FDA
The price of the drug, which is to be administered just once to each patient, will be $373,000.
Ex-HSBC Trader Mark Johnson Awaits Fate on Fraud Charges
Prosecutors say he schemed with others at HSBC to ramp up the price of sterling.
Americans Are Giving Less to Charity Than They Were 10 Years Ago
Philanthropy hasn't recovered from the recession.
Gilead's New Cancer Gene Therapy Has Been Approved by the FDA
The price of the drug, which is to be administered just once to each patient, will be $373,000.
Ex-HSBC Trader Mark Johnson Awaits Fate on Fraud Charges
Prosecutors say he schemed with others at HSBC to ramp up the price of sterling.
Americans Are Giving Less to Charity Than They Were 10 Years Ago
Philanthropy hasn't recovered from the recession.
Fortune 500 Companies in the News
These Viacom Networks Are Coming to Charter's Cheapest Spectrum Cable Service
It's another move in response to cord cutters.
Surface Book 2 Reviews Are In
Machine gets raves for power and battery life, but it could be lighter.
Nielsen Says It Can Measure Netflix Viewership, But Netflix Disagrees
Nielsen has been trying to crack streaming TV ratings for years.
By Kirsten Korosec
Get an Up Close Look at Apple's Project Titan Self-Driving Car
A short video and some expert insight.
By Susie Gharib
This CEO Is Leading a New Wave of Female Entrepreneurs
And bringing in revenues of $50 million.
By Andrew Nusca
Facebook VP David Marcus on Russia Election Meddling: 'Sometimes Bad Things Happen'
But he's confident Facebook can squash bad actors on its social network.